Atripla Prescribing Information from the FDA Web site [PDF]. A more current version may be available on the manufacturer's Web site.
PMID/16421366 Gallant JE, DeJesus E, Arribas JR, Pozniak AL, Gazzard B, Campo RE, Lu B, McColl D, Chuck S, Enejosa J, Toole JJ, Cheng AK; Study 934 Group. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N Engl J Med. 2006 Jan 19;354(3):251-60.
PMID/16556093 Gazzard BG. Use of tenofovir disoproxil fumarate and emtricitabine combination in HIV-infected patients. Expert Opin Pharmacother. 2006 Apr;7(6):793-802. Review.
PMID/17266471 Goicoechea M, Best B. Efavirenz/emtricitabine/tenofovir disoproxil fumarate fixed-dose combination: first-line therapy for all? Expert Opin Pharmacother. 2007 Feb;8(3):371-82.
|
[1] FDA - Atripla Prescribing Information, July 2006, pp. 4, 6. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [2] FDA - Atripla Prescribing Information, July 2006, p. 19. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [3] FDA - FDA Approves the First Once-a-Day Three-Drug Combination Tablet for Treatment of HIV-1. Available at: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01408.html. Accessed 08/06/07. [4] FDA - Atripla Prescribing Information, July 2006, p. 19. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [5] FDA - Atripla Prescribing Information, July 2006, p. 34. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [6] FDA - Atripla Prescribing Information, July 2006, p. 40. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [7] FDA - Atripla Prescribing Information, July 2006, pp. 4, 40. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [8] FDA - Atripla Prescribing Information, July 2006, pp. 4, 40. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [9] FDA - Atripla Prescribing Information, July 2006, p. 40. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [10] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 6. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [11] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 3. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [12] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 3. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [13] Gilead Sciences - Atripla Prescribing Information, May 2007, pp. 6-7. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [14] Gilead Sciences - Atripla Prescribing Information, May 2007, pp. 6-7. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [15] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 7. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [16] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 22. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [17] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 22. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [18] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 4. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [19] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 5. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [20] Gilead Sciences - Atripla Prescribing Information, May 2007, pp. 4-5. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [21] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 34. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [22] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 34. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [23] Gilead Sciences - Atripla Prescribing Information, May 2007, pp. 34-6. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [24] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 39. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [25] Gilead Sciences - Atripla Prescribing Information, May 2007, p. 7. Available at: http://www.gilead.com/pdf/atripla_pi.pdf. Accessed 08/06/07. [26] Merck & Company - Corporate News: Merck & Co., Inc. To Distribute ATRIPLA in Developing Countries [press release], February 16, 2007. Available at: http://www.merck.com/newsroom/press_releases/corporate/2007_0216.html. Accessed 08/06/07. [27] FDA - Atripla Prescribing Information, July 2006, p. 20. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [28] FDA - Atripla Prescribing Information, July 2006, p. 11. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [29] FDA - Atripla Prescribing Information, July 2006, p. 20. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [30] FDA - Atripla Prescribing Information, July 2006, p. 1. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [31] FDA - Atripla Prescribing Information, July 2006, p. 21. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [32] FDA - Atripla Prescribing Information, July 2006, p. 21. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [33] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [34] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [35] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [36] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [37] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [38] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [39] ChemIDplus - Available at: http://chem.sis.nlm.nih.gov/chemidplus/chemidlite.jsp. Accessed 08/06/07. [40] Calculation. - [41] Merck Index - 2001; pp. 622, 630, 1632 [42] Merck Index - 2001; pp. 622, 630 [43] FDA - Atripla Prescribing Information, July 2006, pp. 5-6. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [44] FDA - Atripla Prescribing Information, July 2006, pp. 5-6. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [45] FDA - Atripla Prescribing Information, July 2006, pp. 5-6. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07. [46] FDA - Atripla Prescribing Information, July 2006, pp. 5-6. Available at: http://www.fda.gov/cder/foi/label/2006/021937lbl.pdf. Accessed 08/06/07.
|